Brief: Neuroscientific Biopharmaceuticals Seeks Trading Halt
May 25 (Reuters) - NeuroScientific Biopharmaceuticals Ltd NSB.AX: TRADING HALT TO END ON PROGRAM RESULTS ANNOUNCEMENT OR BY 27 MAY 2026 Further company coverage: NSB.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuroscientific Biopharmaceuticals
See all newsBrief: Neuroscientific Biopharmaceuticals Seeks Trading Halt
Australia's NeuroScientific Biopharmaceuticals surges on positive clinical results
Brief: Neuroscientific Biopharmaceuticals Requests Trading Halt
Brief: Neuroscientific Biopharmaceuticals Appoints Nathan Smith As CEO
Australia's NeuroScientific Biopharmaceuticals soars on buying biotech co